One day, next-generation gene therapies could be used to nudge the body’s own cells to make those proteins at precisely the right time and in just the right amount. CU Boulder biochemistry professor Robert Batey and Alexandria Forbes, Ph.D., founder and CEO of New York-based biotech firm MeiraGTx, are teaming up to explore how to do it.